Microparticulate polyelectrolyte complexes for gentamicin transport across intestinal epithelia

References

• Al-Amoud, A.I., Clark, B.J., Chrystyn, H. (2002). Determination of gentamicin in urine samples after inhalation by reversed-phase high-performance liquid chromatography using pre-column derivatisation with o-phthalaldehyde. J Chromatogr B. 769:89–95.
   PubMed Web of Science ®Google Scholar
• Aungst, B.J. (2000). Intestinal permeation enhancers. J Pharm Sci. 89:429–42.
   PubMed Web of Science ®Google Scholar
• Axelrod, H.R., Kim, J.S., Longley, C.B., Lipka, E., Amidon, G.L., Kakarla, R., Hui, Y.W., Weber, S.J., Choe, S., Sofia, M.J. (1998). Intestinal transport of gentamicin with a novel glycosteroid drug transport agent. Pharm Res. 15:1876–81.
   PubMed Web of Science ®Google Scholar
• Bajpai, S.K., Tankhiwale, R. (2006). Investigation of water uptake behavior and stability of calcium alginate/chitosan bi-polymeric beads: part-1. React Funct Polym. 66:645–58.
   Web of Science ®Google Scholar
• Bystricky, S., Malovikova, A., Sticzay, T. (1990). Interaction of alginates and pectins with cationic polypeptides. Carbohydr Polym. 13:283–94.
   Web of Science ®Google Scholar
• Coppi, G., Iannuccelli, V., Sala, N., Bondi, M. (2004). Alginate microparticles for polymyxin B Peyer’s patches uptake: microparticles for antibiotic oral administration. J Microencapsulation. 21:829–39.
   PubMed Web of Science ®Google Scholar
• des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., Préat, V. (2006). Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Contr Rel. 116:1–27.
   PubMed Web of Science ®Google Scholar
• Dressman, J.B., Reppas, C. (2000). In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci. 11:S73–S80.
   PubMed Web of Science ®Google Scholar
• Ermak, T.H., Dougherty, E.P., Bhagat, H.R., Kabok, Z., Pappo, J. (1995). Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer’s patch M cells. Cell Tissue Res. 279:433–6.
   PubMed Web of Science ®Google Scholar
• Felt, O., Buri, P., Gurny, R. (1998). Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm. 24:979–93.
   PubMed Web of Science ®Google Scholar
• Florence, A.T. (1997). The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm Res. 14:259–66.
   PubMed Web of Science ®Google Scholar
• Giamarellou, H., Zimelis, V.M., Matulionis, D.O., Jackson, G.G. (1975). Assay of aminoglycoside antibiotics in clinical specimens. J Infect Dis. 132:399–406.
   PubMed Web of Science ®Google Scholar
• Gombotz, W.R., Wee, S.F. (1998). Protein release from alginate matrices. Adv Drug Del Rev. 31:267–85.
   PubMed Web of Science ®Google Scholar
• Grant, G.T., Morris, E.R., Rees, D.A., Smith, P.J.C., Thom, D. (1973). Biological interactions between polysaccharides and divalent cations: the egg-box model. Febs Letts. 32:195–8.
   Web of Science ®Google Scholar
• Hu, Z., Tawa, R., Konishi, T., Shibata, N., Takada, K. (2001). A novel emulsifier, Labrasol, enhances gastrointestinal absorption of gentamicin. Life Sci. 69:2899–910.
   PubMed Web of Science ®Google Scholar
• Hussain, N., Jaitley, V., Florence, A.T. (2001). Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Del Rev. 50:107–42.
   PubMed Web of Science ®Google Scholar
• Iannuccelli, V., Coppi, G., Cameroni, R. (1996). Biodegradable intraoperative system for bone infection treatment. I. The drug/polymer interaction. Int J Pharm. 143:195–201.
   Google Scholar
• Ito, Y., Kusawake, T., Ishida, M., Tawa, R., Shibata, N., Takada, K. (2005). Oral solid gentamicin preparation using emulsifier and adsorbent. J Control Release. 105:23–31.
   PubMed Web of Science ®Google Scholar
• Iwanaga, T. (1995). The involvement of macrophages and lymphocytes in the apoptosis of enterocytes. Arch Histol Cytol. 58:151–9.
   PubMed Web of Science ®Google Scholar
• Lertsutthiwong, P., Rojsitthisak, P., Nimmannit, U. (2009). Preparation of turmeric oil-loaded chitosan-alginate biopolymeric nanocapsules. Mat Sci Eng. C29:856–60.
   Web of Science ®Google Scholar
• Mamotani, E., Whipple, D.L., Thiermann, A.B., Cheville, N.F. (1988). Role of M cells and macrophages in the entrance of Mycobacterium paratuberculosis into domes of ileal Peyer’s patches in calves. Vet Pathol. 25:131–7.
   PubMed Web of Science ®Google Scholar
• McClean, S., Prosser, E., Meehan, E., O’Malley, D., Clarke, N., Ramtoola, Z., Brayden, D. (1998). Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia. Eur J Pharm Sci. 6:153–63.
   PubMed Web of Science ®Google Scholar
• Morris, E.R., Rees, D.A., Thom, D., Boyd, J. (1978). Chiroptical and stoichiometric evidence of a specific, primary dimerisation process in alginate gelation. Carbohydr Res. 66:145–54.
   Web of Science ®Google Scholar
• Moyes, S.M., Smyth, S.H., Shipman, A., Long, S., Morris, J.F., Carr, K.E. (2007). Parameters influencing intestinal epithelial permeability and microparticle uptake in vitro. Int J Pharm. 337:133–41.
   PubMed Web of Science ®Google Scholar
• Mumper, R.J., Hoffman, A.S., Puolakkainen, P.A., Bouchard, L.S., Gombo, W.R. (1994). Calcium-alginate beads for the oral delivery of transforming growth factor-β1 (TGF-β1): stabilization of TGF-β1 by the addition of polyacrylic acid within acid-treated beads. J Control Release. 30:241–51.
   Web of Science ®Google Scholar
• Rajaonarivony, M., Vauthier, C., Couarraze, G., Puisieux, F., Couvreur, P. (1993). Development of a new drug carrier made from alginate. J Pharm Sci. 82:912–7.
   PubMed Web of Science ®Google Scholar
• Ross, B.P., DeCruz, S.E., Lynch, T.B., Davis-Goff, K., Toth, I. (2004). Design, synthesis, and evaluation of a lyposaccharide drug delivery agent: application to the gastrointestinal absorption of gentamicin. J Med Chem. 47:1251–8.
   PubMed Web of Science ®Google Scholar
• Sambuy, Y., De Angelis, I., Ranaldi, G., Scarino, M.L., Stammati, A., Zucco, F. (2005). The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 21:1–26.
   PubMed Web of Science ®Google Scholar
• Sarmento, B., Ribeiro, A., Veiga, F., Sampaio, P., Neufeld, R., Ferreira, D. (2007). Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res. 24:2198–206.
   PubMed Web of Science ®Google Scholar
• Segi, N., Yotsuyanagi, T., Ikeda, K. (1989). Interaction of calcium-induced alginate gel beads with propranolol. Chem Pharm Bull. 37:3092–5.
   Web of Science ®Google Scholar
• Sheng, J.J., McNamara, D.P., Amidon, G.L. (2009). Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers. Mol Pharm. 6:29–39.
   PubMed Web of Science ®Google Scholar
• Silva, C.M., Veiga, F., Ribeiro, A.J., Zerrouk, N., Arnaud, P. (2006). Effect of chitosan-coated alginate microspheres on the permeability of Caco-2 cell monolayers. Drug Dev Ind Pharm. 32:1079–88.
   PubMed Web of Science ®Google Scholar
• Sinha, V.R., Singla, A.K., Wadhawan, S., Kaushik, R., Kumria, R., Bansal, K., Dhawan, S. (2004). Chitosan microspheres as a potential carrier for drugs. Int J Pharm. 274:1–33.
   PubMed Web of Science ®Google Scholar
• Snoeck, V., Goddeerls, B., Cox, E. (2005). The role of enterocytes in the intestinal barrier function and antigen uptake. Microbes Infect. 7:997–1004.
   PubMed Web of Science ®Google Scholar
• Stockwell, A.F., Davis, S.S., Walker, S.E. (1986). In vitro evaluation of alginate gel systems as sustained release drug delivery systems. J Control Release. 3:167–75.
   Google Scholar
• Swenson, E.S., Milisen, W.B., Curatolo, W. (1994). Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm Res. 11:1132–42.
   PubMed Web of Science ®Google Scholar
• Takka, S., Acarturk, F. (1999). Calcium alginate microparticles for oral administration: I: effect of sodium alginate type on drug release and drug entrapment efficiency. J Microencapsulation. 16:275–90.
   PubMed Web of Science ®Google Scholar
• Thu, B., Bruheim, P., Espevik, T., Smidsrød, O., Soon-Shiong, P., Skjak-Braek, G. (1996). Alginate polycation microcapsules. I. Interaction between alginate and polycation. Biomaterials. 17:1031–40.
   PubMed Web of Science ®Google Scholar
• Tønnesen, H.H., Karlsen, J. (2002). Alginate in drug delivery systems. Drug Dev Ind Pharm. 28:621–30.
   PubMed Web of Science ®Google Scholar
• van der Lubben, I.M., van Opdorp, F.A.C., Hengeveld, M.R., Onderwater, J.J.M., Koerten, H.K., Verhoef, J.C., Borchard, G., Junginger, H.E. (2002). Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model. J Drug Targeting. 10:449–56.
   PubMed Web of Science ®Google Scholar
• Win, K.J., Feng, S.S. (2005). Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials. 26:2713–22.
   PubMed Web of Science ®Google Scholar
• Wittaya-Areekul, S., Kruenate, J., Prahsarn, C. (2006). Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone. Int J Pharm. 312:113–8.
   PubMed Web of Science ®Google Scholar
• Yamashita, S., Furubayashi, T., Kataoka, M., Sakane, T., Sezaki, H., Tokuda, H. (2000). Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharm Sci. 10:195–204.
   PubMed Web of Science ®Google Scholar
• Yee, S. (1997). In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharm Res. 14:763–6.
   PubMed Web of Science ®Google Scholar